Form 4: Celanese Corp Director Ihlenfeld Reports Phantom Stock Acquisition

Sentiment:

SEC Form 4 Filing


Director Jay V. Ihlenfeld reports acquisition of phantom stock representing dividend equivalents on deferred compensation.

Summary

  • On May 13, 2024, Jay V. Ihlenfeld, a director of Celanese Corp, acquired 43.745 shares of phantom stock.
  • These shares represent dividend equivalents on compensation deferred under the company's 2008 Deferred Compensation Plan.
  • The phantom stock is payable in shares of Common Stock following the termination of Ihlenfeld's service as a director.
  • Following the transaction, Ihlenfeld directly owns 10,057.612 shares of phantom stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, indicating stability and adherence to established compensation plans. It's a neutral event with a slightly positive undertone due to the continued alignment of director interests with shareholder value.

Future Outlook

The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects standard practices for deferred compensation plans and dividend equivalents.

Comparison to Industry Standards

  • Deferred compensation plans and phantom stock awards are common practices among publicly traded companies to incentivize and retain key personnel, including directors.
  • Companies like Dow, DuPont, and BASF also utilize similar compensation strategies to align the interests of their executives with those of the shareholders.
  • The specifics of these plans, such as vesting schedules and payout terms, can vary, but the underlying principle of rewarding long-term service and performance remains consistent.

Stakeholder Impact

  • The acquisition of phantom stock aligns the director's interests with those of the shareholders, as the value of the phantom stock is tied to the performance of Celanese Corp's common stock.

Key Dates

DateDescription
05/13/2024Date of phantom stock acquisition
05/14/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.